J. Exp. Med., Volume 186, Number 12, December 15, 1997 2051-2056

BRIEF DEFINITIVE REPORT:
Targeted Deletion of the Lipopolysaccharide (LPS)-binding Protein Gene Leads to Profound Suppression of LPS Responses Ex Vivo, whereas In Vivo Responses Remain Intact

By Mark M. Wurfel,^* Brian G. Monks,^§ Robin R. Ingalls,^§ Russell L. Dedrick, Russell Delude,^§ Dahua Zhou,^* Norbert Lamping,^** Ralf R. Schumann,^** Rolf Thieringer,^¶ Matthew J. Fenton,^§ Samuel D. Wright,^*¶ and Douglas Golenbock^§

From ^* The Rockefeller University, New York 10021;  The Maxwell Finland Laboratory for Infectious Diseases, Boston, Massachusetts 02118; ^§ Boston University School of Medicine, Boston, Massachusetts 02118;  XOMA Corporation, Berkeley, California 94710; ^¶ Merck Research Laboratories, Rahway, New Jersey 07065; ^** University Medical Center Charité, Humboldt-University, D-10117 Berlin, Germany

Gram-negative bacterial lipopolysaccharide (LPS) stimulates phagocytic leukocytes by interacting with the cell surface protein CD14. Cellular responses to LPS are markedly potentiated by the LPS-binding protein (LBP), a lipid-transfer protein that binds LPS aggregates and transfers LPS monomers to CD14. LBP also transfers LPS to lipoproteins, thereby promoting the neutralization of LPS. LBP present in normal plasma has been shown to enhance the LPS responsiveness of cells in vitro. The role of LBP in promoting LPS responsiveness in vivo was tested in LBP-deficient mice produced by gene targeting in embryonic stem cells. Whole blood from LBP-deficient animals was 1,000-fold less responsive to LPS as assessed by the release of tumor necrosis factor (TNF)-. Blood from gene-targeted mice was devoid of immunoreactive LBP, essentially incapable of transferring LPS to CD14 in vitro, and failed to support cellular responses to LPS. These activities were restored by the addition of exogenous recombinant murine LBP to the plasma. Despite these striking in vitro findings, no significant differences in TNF- levels were observed in plasma from wild-type and LBP-deficient mice injected with LPS. These data suggest the presence of an LBP-independent mechanism for responding to LPS. These LBP knockout mice may provide a tool for discovering the nature of the presumed second mechanism for transferring LPS to responsive cells.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Minter, R. M., Bi, X., Ben-Josef, G., Wang, T., Hu, B., Arbabi, S., Hemmila, M. R., Wang, S. C., Remick, D. G., Su, G. L. (2009). LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G45-G54 [Abstract] [Full Text]  
• Thompson, P. A., Berbee, J. F.P., Rensen, P. C.N., Kitchens, R. L. (2008). Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein. Innate Immunity 14: 365-374 [Abstract]  
• Lloyd-Jones, K. L., Kelly, M. M., Kubes, P. (2008). Varying Importance of Soluble and Membrane CD14 in Endothelial Detection of Lipopolysaccharide. J. Immunol. 181: 1446-1453 [Abstract] [Full Text]  
• Gautier, T., Klein, A., Deckert, V., Desrumaux, C., Ogier, N., Sberna, A.-L., Paul, C., Le Guern, N., Athias, A., Montange, T., Monier, S., Piard, F., Jiang, X.-C., Masson, D., Lagrost, L. (2008). Effect of Plasma Phospholipid Transfer Protein Deficiency on Lethal Endotoxemia in Mice. J. Biol. Chem. 283: 18702-18710 [Abstract] [Full Text]  
• Youn, J. H., Oh, Y. J., Kim, E. S., Choi, J. E., Shin, J.-S. (2008). High Mobility Group Box 1 Protein Binding to Lipopolysaccharide Facilitates Transfer of Lipopolysaccharide to CD14 and Enhances Lipopolysaccharide-Mediated TNF-{alpha} Production in Human Monocytes. J. Immunol. 180: 5067-5074 [Abstract] [Full Text]  
• Knapp, S., von Aulock, S., Leendertse, M., Haslinger, I., Draing, C., Golenbock, D. T., van der Poll, T. (2008). Lipoteichoic Acid-Induced Lung Inflammation Depends on TLR2 and the Concerted Action of TLR4 and the Platelet-Activating Factor Receptor. J. Immunol. 180: 3478-3484 [Abstract] [Full Text]  
• Chien, J. W., Boeckh, M. J., Hansen, J. A., Clark, J. G. (2008). Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation. Blood 111: 2462-2469 [Abstract] [Full Text]  
• Tissieres, P., Dunn-Siegrist, I., Schappi, M., Elson, G., Comte, R., Nobre, V., Pugin, J. (2008). Soluble MD-2 is an acute-phase protein and an opsonin for Gram-negative bacteria. Blood 111: 2122-2131 [Abstract] [Full Text]  
• Knapp, S., Matt, U., Leitinger, N., van der Poll, T. (2007). Oxidized Phospholipids Inhibit Phagocytosis and Impair Outcome in Gram-Negative Sepsis In Vivo. J. Immunol. 178: 993-1001 [Abstract] [Full Text]  
• Lehnert, M., Uehara, T., Bradford, B. U., Lind, H., Zhong, Z., Brenner, D. A., Marzi, I., Lemasters, J. J. (2006). Lipopolysaccharide-binding protein modulates hepatic damage and the inflammatory response after hemorrhagic shock and resuscitation. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G456-G463 [Abstract] [Full Text]  
• Lloyd, K. L., Kubes, P. (2006). GPI-linked endothelial CD14 contributes to the detection of LPS. Am. J. Physiol. Heart Circ. Physiol. 291: H473-H481 [Abstract] [Full Text]  
• Knapp, S., Florquin, S., Golenbock, D. T., van der Poll, T. (2006). Pulmonary Lipopolysaccharide (LPS)-Binding Protein Inhibits the LPS-Induced Lung Inflammation In Vivo.. J. Immunol. 176: 3189-3195 [Abstract] [Full Text]  
• Visintin, A., Halmen, K. A., Latz, E., Monks, B. G., Golenbock, D. T. (2005). Pharmacological Inhibition of Endotoxin Responses Is Achieved by Targeting the TLR4 Coreceptor, MD-2. J. Immunol. 175: 6465-6472 [Abstract] [Full Text]  
• Munford, R. S. (2005). Invited review: Detoxifying endotoxin: time, place and person. Innate Immunity 11: 69-84 [Abstract]  
• Mueller, M., Brandenburg, K., Dedrick, R., Schromm, A. B., Seydel, U. (2005). Phospholipids Inhibit Lipopolysaccharide (LPS)-Induced Cell Activation: A Role for LPS-Binding Protein. J. Immunol. 174: 1091-1096 [Abstract] [Full Text]  
• Wieland, C. W., Knapp, S., Florquin, S., de Vos, A. F., Takeda, K., Akira, S., Golenbock, D. T., Verbon, A., van der Poll, T. (2004). Non-Mannose-capped Lipoarabinomannan Induces Lung Inflammation via Toll-like Receptor 2. Am. J. Respir. Crit. Care Med. 170: 1367-1374 [Abstract] [Full Text]  
• Finberg, R. W., Re, F., Popova, L., Golenbock, D. T., Kurt-Jones, E. A. (2004). Cell activation by Toll-like receptors: role of LBP and CD14. Innate Immunity 10: 413-418 [Abstract]  
• Branger, J., Florquin, S., Knapp, S., Leemans, J. C., Pater, J. M., Speelman, P., Golenbock, D. T., van der Poll, T. (2004). LPS-binding protein-deficient mice have an impaired defense against Gram-negative but not Gram-positive pneumonia. Int Immunol 16: 1605-1611 [Abstract] [Full Text]  
• Kaneko, K., Ueda, R., Kawata, T., Ishizaka, S., Yoshimura, T. (2004). LPS binding protein does not participate in the pharmacokinetics of E5564. Innate Immunity 10: 185-194 [Abstract]  
• Knapp, S., de Vos, A. F., Florquin, S., Golenbock, D. T., van der Poll, T. (2003). Lipopolysaccharide Binding Protein Is an Essential Component of the Innate Immune Response to Escherichia coli Peritonitis in Mice. Infect. Immun. 71: 6747-6753 [Abstract] [Full Text]  
• de Kleijn, D., Pasterkamp, G. (2003). Toll-like receptors in cardiovascular diseases. Cardiovasc Res 60: 58-67 [Abstract] [Full Text]  
• Van Amersfoort, E. S., Van Berkel, T. J. C., Kuiper, J. (2003). Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock. Clin. Microbiol. Rev. 16: 379-414 [Abstract] [Full Text]  
• Janusch, H., Brecker, L., Lindner, B., Alexander, C., Gronow, S., Heine, H., Ulmer, A. J., Rietschel, E. Th., Zahringer, U. (2002). Structural and biological characterization of highly purified hepta-acyl lipid A present in the lipopolysaccharide of the Salmonella enterica sv. Minnesota Re deep rough mutant strain R595. Innate Immunity 8: 343-356 [Abstract]  
• Su, G. L. (2002). Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am. J. Physiol. Gastrointest. Liver Physiol. 283: G256-G265 [Abstract] [Full Text]  
• Fierer, J., Swancutt, M. A., Heumann, D., Golenbock, D. (2002). The Role of Lipopolysaccharide Binding Protein in Resistance to Salmonella Infections in Mice. J. Immunol. 168: 6396-6403 [Abstract] [Full Text]  
• Bingle, C. D., Craven, C. J. (2002). PLUNC: A novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum Mol Genet 11: 937-943 [Abstract] [Full Text]  
• Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U., Wheeler, M. D., Gabele, E., Isayama, F., Thurman, R. G. (2002). Role of Lipopolysaccharide-Binding Protein in Early Alcohol-Induced Liver Injury in Mice. J. Immunol. 168: 2963-2969 [Abstract] [Full Text]  
• Zweigner, J., Gramm, H.-J., Singer, O. C., Wegscheider, K., Schumann, R. R. (2001). High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 98: 3800-3808 [Abstract] [Full Text]  
• Heumann, D. (2001). CD14 and LBP in endotoxemia and infections caused by Gram-negative bacteria. Innate Immunity 7: 439-441 [Abstract]  
• Gutsmann, T., Muller, M., Carroll, S. F., MacKenzie, R. C., Wiese, A., Seydel, U. (2001). Dual Role of Lipopolysaccharide (LPS)-Binding Protein in Neutralization of LPS and Enhancement of LPS-Induced Activation of Mononuclear Cells. Infect. Immun. 69: 6942-6950 [Abstract] [Full Text]  
• Song, P. I., Abraham, T. A., Park, Y., Zivony, A. S., Harten, B., Edelhauser, H. F., Ward, S. L., Armstrong, C. A., Ansel, J. C. (2001). The Expression of Functional LPS Receptor Proteins CD14 And Toll-Like Receptor 4 in Human Corneal Cells. IOVS 42: 2867-2877 [Abstract] [Full Text]  
• Diks, S. H., van Deventer, S. J.H., Peppelenbosch, M. P. (2001). Invited review: Lipopolysaccharide recognition, internalisation, signalling and other cellular effects. Innate Immunity 7: 335-348 [Abstract]  
• Heinrich, J.-M., Bernheiden, M., Minigo, G., Yang, K. K., Schutt, C., Mannel, D. N., Jack, R. S. (2001). The Essential Role of Lipopolysaccharide-Binding Protein in Protection of Mice Against a Peritoneal Salmonella Infection Involves the Rapid Induction of an Inflammatory Response. J. Immunol. 167: 1624-1628 [Abstract] [Full Text]  
• Alexander, C., Rietschel, E. Th. (2001). Invited review: Bacterial lipopolysaccharides and innate immunity. Innate Immunity 7: 167-202 [Abstract]  
• Strohmeier, G. R., Walsh, J. H., Klings, E. S., Farber, H. W., Cruikshank, W. W., Center, D. M., Fenton, M. J. (2001). Lipopolysaccharide Binding Protein Potentiates Airway Reactivity in a Murine Model of Allergic Asthma. J. Immunol. 166: 2063-2070 [Abstract] [Full Text]  
• Heumann, D., Adachi, Y., Le Roy, D., Ohno, N., Yadomae, T., Glauser, M. P., Calandra, T. (2001). Role of Plasma, Lipopolysaccharide-Binding Protein, and CD14 in Response of Mouse Peritoneal Exudate Macrophages to Endotoxin. Infect. Immun. 69: 378-385 [Abstract] [Full Text]  
• Moore, K. J., Andersson, L. P., Ingalls, R. R., Monks, B. G., Li, R., Arnaout, M. A., Golenbock, D. T., Freeman, M. W. (2000). Divergent Response to LPS and Bacteria in CD14-Deficient Murine Macrophages. J. Immunol. 165: 4272-4280 [Abstract] [Full Text]  
• Ermert, M., Merkle, M., Mootz, R., Grimminger, F., Seeger, W., Ermert, L. (2000). Endotoxin priming of the cyclooxygenase-2-thromboxane axis in isolated rat lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 278: L1195-L1203 [Abstract] [Full Text]  
• Netea, M. G., Fantuzzi, G., Kullberg, B. J., Stuyt, R. J. L., Pulido, E. J., McIntyre, R. C. Jr., Joosten, L. A. B., Van der Meer, J. W. M., Dinarello, C. A. (2000). Neutralization of IL-18 Reduces Neutrophil Tissue Accumulation and Protects Mice Against Lethal Escherichia coli and Salmonella typhimurium Endotoxemia. J. Immunol. 164: 2644-2649 [Abstract] [Full Text]  
• Le Roy, D., Di Padova, F., Tees, R., Lengacher, S., Landmann, R., Glauser, M. P., Calandra, T., Heumann, D. (1999). Monoclonal Antibodies to Murine Lipopolysaccharide (LPS)-Binding Protein (LBP) Protect Mice from Lethal Endotoxemia by Blocking Either the Binding of LPS to LBP or the Presentation of LPS/LBP Complexes to CD14. J. Immunol. 162: 7454-7460 [Abstract] [Full Text]  
• Forestier, C., Moreno, E., Pizarro-Cerda, J., Gorvel, J.-P. (1999). Lysosomal Accumulation and Recycling of Lipopolysaccharide to the Cell Surface of Murine Macrophages, an In Vitro and In Vivo Study. J. Immunol. 162: 6784-6791 [Abstract] [Full Text]  
• Kitchens, R. L., Wang, P.-y., Munford, R. S. (1998). Bacterial Lipopolysaccharide Can Enter Monocytes Via Two CD14-Dependent Pathways. J. Immunol. 161: 5534-5545 [Abstract] [Full Text]  
• Wang, P.-y., Kitchens, R. L., Munford, R. S. (1998). Phosphatidylinositides Bind to Plasma Membrane CD14 and Can Prevent Monocyte Activation by Bacterial Lipopolysaccharide. J. Biol. Chem. 273: 24309-24313 [Abstract] [Full Text]  
• Pan, Z., Zhou, L., Hetherington, C. J., Zhang, D.-E. (2000). Hepatocytes Contribute to Soluble CD14 Production, and CD14 Expression Is Differentially Regulated in Hepatocytes and Monocytes. J. Biol. Chem. 275: 36430-36435 [Abstract] [Full Text]  
• Lien, E., Chow, J. C., Hawkins, L. D., McGuinness, P. D., Miyake, K., Espevik, T., Gusovsky, F., Golenbock, D. T. (2001). A Novel Synthetic Acyclic Lipid A-like Agonist Activates Cells via the Lipopolysaccharide/Toll-like Receptor 4 Signaling Pathway. J. Biol. Chem. 276: 1873-1880 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS